Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10798085 | 0.83 | TSHR (0.42) | ALDH1A1 | |
| SCHEMBL4349604 | 0.82 | CYP2C19 (0.34) | ALDH1A1 | |
| SCHEMBL8980371 | 0.81 | CYP3A4 (0.33) | ALDH1A1 | |
| SCHEMBL10427583 | 0.80 | — | — | |
| SCHEMBL18101495 | 0.79 | TSHR (0.33) | ALDH1A1 | |
| SCHEMBL10954179 | 0.77 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL10954184 | 0.77 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL8828061 | 0.76 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL11468671 | 0.75 | LMNA (0.39) | ALDH1A1 | |
| SCHEMBL25302536 | 0.75 | CYP2C19 (0.37) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7524978-B2 | 2-oxabicyclo[3.3.0]octane compounds, process for producing the same, optical resolver, method of separating diastereomer mixture, and method of optically resolving alcohol | ZEON CORPORATION (JP) | 2009-04-28 | — | — | US | disclosed |
| US-7524978-B2 | 2-oxabicyclo[3.3.0]octane compounds, process for producing the same, optical resolver, method of separating diastereomer mixture, and method of optically resolving alcohol | ZEON CORPORATION (JP) | 2009-04-28 | — | — | US | disclosed |
| US-20060205960-A1 | 2-Oxabicyclo[3.3.0]octane compounds, process for producing the same, optical resolver, method of separating diastereomer mixture, and method of optically resolving alcohol | ZEON CORPORATION (JP) | 2006-09-14 | — | — | US | disclosed |
| EP-1535917-A1 | 2-OXABICYCLO 3.3.0 OCTANE COMPOUNDS, PROCESS FOR PRODUCING THE SAME, OPTICAL RESOLVER, METHOD OF SEPARATING DIASTEREOMER MIXTURE, AND METHOD OF OPTICALLY RESOLVING ALCOHOL | Zeon Corporation (JP) | 2005-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060205960-A1 | 2-Oxabicyclo[3.3.0]octane compounds, process for producing the same, optical resolver, method of separating diastereomer mixture, and method of optically resolving alcohol | OXER1, OR10J3, ADH1A | ALDH1A1 78/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.